An association between the DAT1 polymorphism and smoking behavior in young adults from the National Longitudinal Study of Adolescent Health

Health Psychology

Volumn 25, Issue 2, 2006, Pages 190-197

  Timberlake, David S ^a   Haberstick, Brett C ^a   Lessem, Jeffrey M ^a   Smolen, Andrew ^a   Ehringer, Marissa ^a   Hewitt, John K ^a   Hopfer, Christian ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Dopamine; Genetics; Heritability; Smoking; Young adults

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; DOPAMINE TRANSPORTER 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADOLESCENT HEALTH; ADULT; ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DOPAMINE RELEASE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRAIT; HERITABILITY; HUMAN; LONGITUDINAL STUDY; MALE; SMOKING; VARIANCE;

ADOLESCENT; ADULT; CHEEK; FEMALE; HUMANS; INTERVIEWS; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SIBLINGS; SMOKING; UNITED STATES;

EID: 33645784017     PISSN: 02786133     EISSN: None     Source Type: Journal    
DOI: 10.1037/0278-6133.25.2.190     Document Type: Article

References (42)

1. Abecasis, G. R., Cardon, L. R., & Cookson, W. O. (2000). A general test of association for quantitative traits in nuclear families. American Journal of Human Genetics, 66, 279-292.
2. Anchordoquy, H. C., McGeary, C., Liu, L., Krauter, K. S., & Smolen, A. (2003). Genotyping of three candidate genes after whole-genome pre-amplification of DNA collected from buccal cells. Behavior Genetics, 33, 73-78.
3. Bierut, L. J., Rice, J. P., Edenberg, H. J., Goate, A., Foroud, T., Cloninger, C. R., et al. (2000). Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. American Journal of Medical Genetics, 90, 299-302.
4. Chantala, K. (2001). Constructing weights to use in analyzing pairs of individuals from Add Health data. Chapel Hill: Carolina Population Center, University of North Carolina.
5. Colder, C. R., Mehta, P., Balanda, K., Campbell, R. T., Mayhew, K. P., Stanton, W. R., et al. (2001). Identifying trajectories of adolescent smoking: An application of latent growth mixture modeling. Health Psychology, 20, 127-135.
6. Comings, D. E., Ferry, L., Bradshaw-Robinson, S., Burchette, R., Chiu, C., & Muhleman, D. (1996). The dopamine D2 receptor (DRD2) gene: A genetic risk factor in smoking. Pharmacogenetics, 6, 73-79.
7. Contin, M., Martinelli, P., Mochi, M., Albani, F., Riva, R., Scaglione, C., et al. (2004). Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease. Clinical Neuropharmacology, 27, 111-115.
8. Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994). Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Research, 653, 278-284.
9. Dani, J. A. (2003). Roles of dopamine signaling in nicotine addiction. Molecular Psychiatry, 8, 255-256.
10. Fuke, S., Suo, S., Takahashi, N., Koike, H., Sasagawa, N., & Ishiura, S. (2001). The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics Journal, 1, 152-156.
11. Fulker, D. W., Cherny, S. S., Sham, P. C., & Hewitt, J. K. (1999). Combined linkage and association sib-pair analysis for quantitative traits. American Journal of Human Genetics, 64, 259-267.
12. Goodman, E., & Capitman, J. (2000). Depressive symptoms and cigarette smoking among teens. Pediatrics, 106, 748-755.
13. Grady, S. R., Murphy, K. L., Cao, J., Marks, M. J., McIntosh, J. M., & Collins, A. C. (2002). Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions. Journal of Pharmacology and Experimental Therapeutics, 301, 651-660.
14. Haberstick, B. C., & Smolen, A. (2004). Genotyping of three single nucleotide polymorphisms following whole genome preamplification of DNA collected from buccal cells. Behavior Genetics, 34, 541-547.
15. Heinz, A., Goldman, D., Jones, D. W., Palmour, R., Hommer, D., Gorey, J. G., et al. (2000). Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology, 22, 133-139.
16. Hirschhorn, J. N., Lohmueller, K., Byrne, E., & Hirschhorn, K. (2002). A comprehensive review of genetic association studies. Genetics in Medicine, 4, 45-61.
17. Jacobsen, L. K., Staley, J. K., Zoghbi, S. S., Seibyl, J. P., Kosten, T. R., Innis, R. B., et al. (2000). Prediction of dopamine transporter binding availability by genotype: A preliminary report. American Journal of Psychiatry, 157, 1700-1703.
18. Jorm, A. F., Henderson, A. S., Jacomb, P. A., Christensen, H., Korten, A. E., Rodgers, B., et al. (2000). Association of smoking and personality with a polymorphism of the dopamine transporter gene: Results from a community survey. American Journal of Medical Genetics, 96, 331-334.
19. Kendler, K. S., Neale, M. C., Sullivan, P., Corey, L. A., Gardner, C. O., & Prescott, C. A. (1999). A population-based twin study in women of smoking initiation and nicotine dependence. Psychological Medicine, 29, 299-308.
20. Koob, G. F., & Le Moal, M. (1997, October 3). Drug abuse: Hedonic homeostatic dysregulation. Science, 278, 52-58.
21. Koopmans, J. R., Slutske, W. S., Heath, A. C., Neale, M. C., & Boomsma, D. I. (1999). The genetics of smoking initiation and quantity smoked in Dutch adolescent and young adult twins. Behavior Genetics, 29, 383-393.
22. Kozlowski, L. T. (1991). Rehabilitating a genetic perspective in the study of tobacco and alcohol use. British Journal of Addiction, 86, 517-520.
23. Kozlowski, L. T., & Harford, M. R. (1976). On the significance of never using a drug: An example from cigarette smoking. Journal of Abnormal Psychology, 85, 433-434.
24. Lerman, C., Caporaso, N. E., Audrain, J., Main, D., Bowman, E. D., Lockshin, B., et al. (1999). Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychology, 18, 14-20.
25. Lerman, C., Shields, P. G., Wileyto, E. P., Audrain, J., Hawk, L. H., Jr., Pinto, A., et al. (2003). Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychology, 22, 541-548.
26. Lerman, C., & Swan, G. E. (2002). Non-replication of genetic association studies: Is DAT all, folks? Nicotine & Tobacco Research, 4, 247-249.
27. Maes, H. H., Sullivan, P. F., Bulik, C. M., Neale, M. C., Prescott, C. A., Eaves, L. J., et al. (2004). A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychological Medicine, 34, 1251-1261.
28. Martinez, D., Gelernter, J., Abi-Dargham, A., van Dyck, C. H., Kegeles, L., Innis, R. B., et al. (2001). The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology, 24, 553-560.
29. Neale, M. C., Boker, S. M., Xie, G., & Maes, H. H. (2002). Mx: Statistical modeling (6th ed.). Richmond, VA: Virginia Commonwealth University, Department of Psychiatry.
30. Neale, M. C., & Cardon, L. R. (1992). Methodology for genetic studies of twins and families (Vol. 67). Dordrecht, the Netherlands: Kluwer Academic Publishers.
31. Noble, E. P., Blum, K., Ritchie, T., Montgomery, A., & Sheridan, P. J. (1991). Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Archives of General Psychiatry, 48, 648-654.
32. Noble, E. P., St Jeor, S. T., Ritchie, T., Syndulko, K., St Jeor, S. C., Fitch, R. J., et al. (1994). D2 dopamine receptor gene and cigarette smoking: A reward gene? Medical Hypotheses, 42, 257-260.
33. Pontieri, F. E., Tanda, G., Orzi, F., & Di Chiara, G. (1996, July 18). Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature, 382, 255-257.
34. Sabol, S. Z., Nelson, M. L., Fisher, C., Gunzerath, L., Brody, C. L., Hu, S., et al. (1999). A genetic association for cigarette smoking behavior. Health Psychology, 18, 7-13.
35. SAS. (1990). SAS/STAT user's guide (4th ed., Vols. 1-2). Cary, NC: Author.
36. Schulze, T. G., & McMahon, F. J. (2002). Genetic association mapping at the crossroads: Which test and why? Overview and practical guidelines. American Journal of Medical Genetics, 114, 1-11.
37. Smolen, A., & Hewitt, J. K. (2003). Biomarkers in Wave III of the Add Health study. Retrieved from University of Colorado, Institute for Behavioral Genetics Web site: http://www.cpc.unc.edu/addhealth/
38. Spielman, R. S., McGinnis, R. E., & Ewens, W. J. (1993). Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). American Journal of Human Genetics, 52, 506-516.
39. Tourangeau, R., & Hee-Choon, S. (1998). National Longitudinal Study of Adolescent Health grand sample weight. Chapel Hill: Carolina Population Center, University of North Carolina.
40. Vandenbergh, D. J., Bennett, C. J., Grant, M. D., Strasser, A. A., O'Connor, R., Stauffer, R. L., et al. (2002). Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: Failure to replicate and finding that never-smokers may be different. Nicotine & Tobacco Research, 4, 333-340.
41. Vandenbergh, D. J., Persico, A. M., Hawkins, A. L., Griffin, C. A., Li, X., Jabs, E. W., et al. (1992). Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics, 14, 1104-1106.
42. Young, S. E., Smolen, A., Corley, R. P., Krauter, K. S., DeFries, J. C., Crowley, T. J., et al. (2002). Dopamine transporter polymorphism associated with externalizing behavior problems in children. American Journal of Medical Genetics, 114, 144-149.